
Ifosfamide-based chemotherapy yields high survival rate for treatment of osteosarcoma

August 2020
Ifosfamide-based chemotherapy yields high survival rate for treatment of osteosarcoma
Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:N/A
Efficacy and safety of ifosfamide-based chemotherapy for osteosarcoma: a meta-analysis
Drug Des Devel Ther. 2015 Nov 4;9:5925-32Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Seven randomized controlled trials with 2,529 patients with histologically confirmed osteosarcoma were included in this meta-analysis. The purpose of this study was to compare the safety and efficacy of ifosfamide-based chemotherapy to a control group receiving chemotherapy without ifosfamide. The results displayed that ifosfamide-based chemotherapy had significantly higher event-free survival, ov...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Join the Conversation
Please Login or Join to leave comments.